InvestorsHub Logo
Post# of 251936
Next 10
Followers 829
Posts 119689
Boards Moderated 16
Alias Born 09/05/2002

Re: AlpineBV_Miller post# 124445

Thursday, 08/04/2011 11:52:04 AM

Thursday, August 04, 2011 11:52:04 AM

Post# of 251936
DNDN—Whether you characterize the problem as cash flow, reimbursement risk, cash density, or some other creative appellation, the salient point appears to be that the end-user demand for Provenge is less than many people thought until yesterday.

We will not see DNDN sporting a $5B+ enterprise value ever again, IMHO.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.